Healthcare - Biotechnology - NASDAQ - US
$ 1.0
0 %
$ 1.55 M
Market Cap
-0.16
P/E
BALANCE SHEET
12.2 M
ASSETS
21.3 M
LIABILITIES
-9.12 M
EQUITY
BALANCE SHEET DECOMPOSITION
Balance Sheet Decomposition
Kiromic BioPharma, Inc.
| Current Assets | 4.43 M |
| Cash & Short-Term Investments | 3.2 M |
| Receivables | 0 |
| Other Current Assets | 1.23 M |
| Non-Current Assets | 7.74 M |
| Long-Term Investments | 0 |
| PP&E | 7.72 M |
| Other Non-Current Assets | 21.4 K |
| Current Liabilities | 20.4 M |
| Accounts Payable | 2.14 M |
| Short-Term Debt | 14.6 M |
| Other Current Liabilities | 3.61 M |
| Non-Current Liabilities | 912 K |
| Long-Term Debt | 912 K |
| Other Non-Current Liabilities | 0 |
Balance Sheet
Millions
| Dec-2023 | Dec-2022 | Dec-2021 | Dec-2020 | Dec-2019 | Dec-2018 | |
|---|---|---|---|---|---|---|
| ASSETS | ||||||
| Cash & Cash Equivalents | 3.2 | 0.6 | 25.4 | 10.2 | 1.9 | 0.4 |
| Short Term Investments | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | 0 | 0 | 16.2 K | 0 | 0 | 24.3 K |
| Inventory | 0 | 0 | 0 | 0 | 22.2 K | 16.3 K |
| Other Current Assets | 1.2 | 1.0 | 3.4 | 1.2 | 89.1 K | 0.1 |
| Total Current Assets | 4.4 | 1.7 | 27.1 | 10.7 | 2.0 | 0.6 |
| PP&E | 7.7 | 10.3 | 3.6 | 2.1 | 0.6 | 0.3 |
| Intangible Assets | 0 | 0 | 0 | 0 | 0 | 0 |
| Goodwill | 0 | 0 | 0 | 0 | 0 | 0 |
| Long Term Investments | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Long Term Assets | 21.4 K | 24.4 K | 31.1 K | 24.4 K | 24.4 K | 17.8 K |
| Other Assets | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Assets | 12.2 | 12.0 | 30.7 | 12.8 | 2.7 | 0.9 |
| LIABILITIES | ||||||
| Accounts Payable | 2.1 | 7.3 | 2.2 | 0.7 | 0.5 | 0.2 |
| Short Term Debt | 14.6 | 5.0 | 0.5 | 0.5 | 0 | 0 |
| Other Current Liabilities | 3.6 | 1.0 | 0.7 | 0.3 | 0.2 | 0.4 |
| Total Current Liabilities | 20.4 | 13.3 | 3.4 | 1.5 | 0.7 | 0.6 |
| Long Term Debt | 0.9 | 4.5 | 0 | 0 | 0 | 0 |
| Deferred Tax Income | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Liabilities | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Liabilities | 21.3 | 17.7 | 3.4 | 1.5 | 0.7 | 0.6 |
| EQUITY | ||||||
| Common Stock | 1.26 K | 648 | 9.3 K | 1.2 K | 0 | 0 |
| Retained Earnings | (122.9) | (101.9) | (67.2) | (41.6) | (22.4) | (18.7) |
| Other Accumulative Comprehensive Income/Loss | 2 | 0 | 0 | 0 | 0 | (0.3) |
| Total Equity | (9.1) | (5.8) | 27.3 | 11.4 | 2.0 | 0.3 |
| Total Liabilities and Equity | 12.2 | 12.0 | 30.7 | 12.8 | 2.7 | 0.9 |
| SHARES OUTSTANDING | ||||||
| Common Shares Outstanding | 1.1 | 0.5 | 0.4 | 0.2 | 0.1 | 0.1 |